Investment
Features
FeesSafety
Academy
More
Pluang+

Compare FuelCell Energy Inc (FCEL) vs Recursion Pharmaceuticals Inc (RXRX) Price & Performance

FuelCell Energy IncTrade
Recursion Pharmaceuticals IncTrade

Price performance (Past 24H)

Key statistics

FuelCell Energy Inc vs Recursion Pharmaceuticals Inc — how do they compare? FuelCell Energy Inc trades at $19.69 (market cap $1.59B), while Recursion Pharmaceuticals Inc trades at $3.35 (market cap $1.78B). The key difference: FuelCell Energy Inc and Recursion Pharmaceuticals Inc are close in size by market cap, and FuelCell Energy Inc is trading nearer its 52-week high, Recursion Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.

FCELRXRX
Market Cap
$1.59B$1.78B
Sector
IndustrialsHealth
52-Week High
$36.01$6.79
52-Week Low
$3.92$2.84
Enterprise Value
$1.43B$1.30B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

FuelCell Energy Inc

No Aura AI signal available yet.

Recursion Pharmaceuticals Inc

RXRX trades at $3.22, up 1.26% today, with a neutral technical signal and bearish moving averages. The company reported a Q2 2026 EPS miss of -$0.25 versus -$0.24 expected, with revenue declining year-over-year. Financials show steep losses, including a net income margin of -961.97% in 2026, though cash flow from financing activities provides a runway through early 2028. Recent news highlights partnership progress with Genentech but notes competitive pressures and slow revenue growth.

Outlook remains speculative due to high cash burn and unproven commercial scalability, posing significant risk. Analyst consensus is mixed with 40% buy ratings, reflecting optimism for AI-driven drug discovery potential against persistent profitability challenges. Investment appeal hinges on pipeline milestones, but current fundamentals warrant caution.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About FuelCell Energy Inc

FuelCell Energy Inc is a fuel-cell power company. FuelCell designs manufactures, sells, installs, operates, and services fuel cell products, which efficiently convert chemical energy in fuels into electricity through a series of chemical reactions. It serves various industries such as Industrial, Wastewater treatment, Commercial and Hospitality, Data centers and Communications, Education and Healthcare, and others. Geographically, the company generates a majority of its revenue from the United States followed by South Korea.

Read more on FCEL

About Recursion Pharmaceuticals Inc

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.

Read more on RXRX